Transcatheter aortic valve replacement (TAVR) is an established treatment for severe,
symptomatic, aortic stenosis (AS) in patients of all risk categories and now comprises 12.5 …

Paravalvular leak (PVL) is a complication that occurs in 5–17% of patients after surgical
prosthetic valve implantation. Whereas PVLs can be benign, some PVLs are associated with …

Background: Transcatheter closure of a symptomatic prosthetic paravalvular leak (PVL) is
feasible, but there is presently no conclusive evidence to show consistent efficacy. We …

Percutaneous paravalvular leak (PVL) closure has emerged as a feasible alternative to redo
valve surgery. However, comparative data on percutaneous and surgical treatment of PVL …

Objectives The objective of this study was to determine the safety and efficacy of intracardiac
echocardiography (ICE) to guide percutaneous paravalvular leak (PVL) closure …

Mitral paravalvular leaks (PVLs) commonly occur in patients with prosthetic valves.
Paravalvular defects may be clinically inconsequential and may aggravate hemolysis or …

Prosthetic paravalvular leaks (PVLs) are associated with congestive heart failure and
hemolysis. Surgical PVL closure carries high risks. Transcatheter implantation of occluding …

Background Paravalvular leak (PVL) is often seen after aortic (AV) and mitral valve (MV)
surgery, either due to infection or valve dehiscence. We sought to describe predictors of …

Objectives: This study sought to assess the relative merit of surgical correction (SC) versus
transcatheter reduction on long-term outcomes in patients with significant paravalvular leak …

Background CORKNOT® facilitates a reduction in cardiopulmonary bypass (CPB) time,
aortic cross clamp (ACC) time and operative time, but reported to be associated with other …